The largest database of trusted experimental protocols

Statistical package for the social sciences v 13

Manufactured by IBM
Sourced in United States

The Statistical Package for the Social Sciences (SPSS) v.13 is a software application designed for statistical analysis. It provides a comprehensive set of tools for data management, analysis, and visualization. SPSS v.13 is widely used in various fields, including social sciences, market research, and healthcare.

Automatically generated - may contain errors

17 protocols using statistical package for the social sciences v 13

1

Multivariate Analysis of Mortality and Hospitalization Outcomes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Values are expressed as mean ± SD or percentage. Differences between study groups were analysed using ANOVA with Bonferroni post-hoc analysis, Student t or chi-square tests. Relationships between variables were evaluated by Pearson correlation and multiple linear regression or multiple logistic regression models.
Kaplan-Meier curves and log rank tests of both mortality and hospitalizations were performed after stratifying by analysis subgroups. On multivariate Cox regression analysis, variables were included if they were independently associated with both the outcome and the exposure (p < 0·05) or if they modified the risk ratio estimate for any of the remaining covariates (> 0·5% change). Survival models were always adjusted for age, sex, pack-years, body mass index, Charlson index and current treatment. As an additional analysis, Poisson regression with overdispersion correction by Pearson were used to assess the significance of the weighted rate ratios for hospitalization.
All effects were considered significant with a p value < 0·05. Statistical analyses were performed using the Statistical Package for the Social Sciences, v13.0 (SPSS Inc, Chicago, IL, USA) and SAS for Windows statistical software, v9.2 (SAS Institute, Inc., Carey, NC, USA).
+ Open protocol
+ Expand
2

Body Composition Changes in Athletes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Data analysis was performed using the Statistical Package for the Social Sciences (v13.0, SPSS Inc., Chicago, IL, USA). Descriptive statistics, Kolmogorov–Smirnov (normality of the distribution) and Levene's (homogeneity of variance) tests were calculated for all experimental data before inferential testing. Changes in body composition parameters were compared over the training period for players in the two experimental and control groups using two-factor (group x time) univariate analysis of variance (ANOVA). Effect size (ES) were classified as follows: <0.2 was defined as trivial, 0.2–0.6 was defined as small, 0.6–1.2 was defined as moderate, 1.2–2.0 was defined as large, >2.0 was defined as very large and >4.0 was defined as extremely large [21 (link)]. Statistical significance was set at p < 0.05.
+ Open protocol
+ Expand
3

Evaluating Physical Fitness Outcomes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Data analysis was performed using the Statistical Package for the Social Sciences (v13.0, SPSS Inc., Chicago, IL, USA). Descriptive statistics, Kolmogorov–Smirnov (normality of the distribution) and Levene’s (homogeneity of variance) tests were calculated for all experimental data before inferential testing. Changes in health-related physical fitness parameters were compared over the training period for players in the two experimental and control groups using two-factor (group x time) univariate analysis of variance (ANOVA). If the appropriate statistical significance was identified, then the Bonferroni post-hoc test was used to further distinguish the differences among groups. Cohen d effect sizes (ES) were also calculated to determine the magnitude of the group differences in health-related physical fitness. ES was classified as follows: <0.2 was defined as trivial; 0.2–0.6 was defined as small; 0.6–1.2 was defined as moderate; 1.2–2.0 was defined as large; >2.0 was defined as very large; and >4.0 was defined as extremely large [39 (link)]. The Kolmogorov-Smirnov tests showed that data were normally distributed, and no violation of homogeneity of variance was found using Levene’s test. The statistical significance was set at p<0.05.
+ Open protocol
+ Expand
4

Statistical Analysis of Experimental Data

Check if the same lab product or an alternative is used in the 5 most similar protocols
Statistical Package for the Social Sciences v13.0 (SPSS Inc., USA) was used for statistical analysis. Results are presented as mean ± SD of the mean of at least triplicates. The main test used was the χ2 test; P ≤ 0.05 indicated statistical significance.
+ Open protocol
+ Expand
5

Bioluminescent Assay for Comparative Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The data generated in this study have been presented as the mean ± standard error (S.E.). All experiments were conducted at least twice, and the bioluminescent assays were conducted at least in triplicate. For analyzing pairwise samples, the Student’s t-test was employed. Statistical comparisons were conducted utilizing SigmaPlot (San Jose, CA, USA) and the Statistical Package for the Social Sciences v.13 (SPSS) from Chicago, IL, USA.
+ Open protocol
+ Expand
6

Comprehensive Statistical Analysis of Experimental Data

Check if the same lab product or an alternative is used in the 5 most similar protocols
All data were expressed as mean ± error, and student t-test analysis was performed for the pairwise samples. All statistical comparisons were performed using SigmaPlot graphing software (San Jose, CA, USA) and Statistical Package for the Social Sciences v.13 (SPSS, Chicago, IL, USA). A p-value < 0.05 was considered statistically significant, and all statistical tests were two-sided.
+ Open protocol
+ Expand
7

Biochemical Recurrence-Free Survival Rate

Check if the same lab product or an alternative is used in the 5 most similar protocols
The biochemical recurrence-free survival (BCRFS) rate was estimated using the Kaplan-Meier method. The analysis was performed using Statistical Package for the Social Sciences v.13 (SPSS, Chicago, IL, USA). All 30 procedures were performed by two experienced surgeons (each with experience of > 300 EERPEs).
+ Open protocol
+ Expand
8

Statistical Analysis of Experimental Data

Check if the same lab product or an alternative is used in the 5 most similar protocols
All data were expressed as mean ± SD and performed student t-test analysis for the pairwise samples. All statistical comparisons were performed using the SigmaPlot graphing software (San Jose, CA, USA) and the Statistical Package for the Social Sciences v.13 (SPSS, Chicago, IL, USA). A P-value <0.05 was considered statistically significant and all statistical tests were two-sided.
+ Open protocol
+ Expand
9

Statistical Analysis of Experimental Data

Check if the same lab product or an alternative is used in the 5 most similar protocols
All data are expressed as the mean ± standard error, and the differences were analyzed by Student’s t-test for pairwise samples. All statistical comparisons were performed using SigmaPlot graphing software (Systat Software, San Jose, CA, USA) and Statistical Package for the Social Sciences v.13 (SPSS, Chicago, IL, USA). A p-value<0.05 was considered statistically significant, and all statistical tests were two-sided.
+ Open protocol
+ Expand
10

Cytokine Expression Regulation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The data are expressed as the mean ± SEM of at least three independent experiments. Statistical analysis was performed using one-way analysis of variance (ANOVA) followed by Bonferroni's multiple comparison tests. *p <0.05; **p<0.01; and ***p<0.001 were considered statistically significant. All statistical comparisons were performed using SigmaPlot software and Statistical Package for the Social Sciences v.13 (SPSS, Inc., Chicago, IL, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!